The DOI matches its Crossref record; 142 of the 143 references it cites were found in a registry or an index.
Mechanisms Governing Metastatic Dormancy and Reactivation
Open accessAbstract
Many cancer patients suffer from metastatic relapse several years after they have undergone radical surgery. Early cancer cell dissemination followed by a protracted period of dormancy potentially explains this prevalent clinical behavior. Increasing evidence suggests that the metastasis-initiating cells are cancer stem cells or revert to this functional state upon infiltrating a target organ. Their entry into dormancy and subsequent reactivation are governed by intrinsic programs and by contextual cues, which resemble those regulating the self-renewal capability of adult stem cells. In addition, metastatic cells undergoing reactivation are nursed by specialized extracellular matrix niches, which support positive signals, such as Wnt and Notch, and attenuate negative signals, such as BMP. In spite of significant remaining uncertainties, these findings provide a framework to understand the logic of metastatic dormancy and reactivation and open new avenues for therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The analogy between senescence and dormancy in some tumours also implies that the in vivo senescence-like arrest may be unstable, because dormant tumour cells can regrow after long periods of time 130,140”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [140]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M. W., Reinhard, F., Zhang, C. C., Shipitsin, M. V., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,839
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
A Perspective on Cancer Cell Metastasis
Chaffer, C. L., & Weinberg, R. A. (2011) · Science · doi:10.1126/science.1203543 · Cited by 4,905
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Flagged first, then by citations
1 of the 143 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 587
Regulation of cancer stem cells in triple negative breast cancer
Fultang, N., Chakraborty, M., & Peethambaran, B. (2021) · Cancer Drug Resistance · doi:10.20517/cdr.2020.106 · Cited by 101
Phenotype Switching and the Melanoma Microenvironment; Impact on Immunotherapy and Drug Resistance
Hossain, S. M., & Eccles, M. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021601 · Cited by 98
Wnt/Beta-Catenin Signaling and Prostate Cancer Therapy Resistance
Yeh, Y. A., Guo, Q., Connelly, Z. M., Cheng, S., Yang, S., Prieto‐Domínguez, N., & Yu, X. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32656-2_16 · Cited by 94
Ouyang, L., Yan, B., Liu, Y., Mao, C., Wang, M., Liu, N., Wang, Z., Liu, S., Shi, Y., Chen, L., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0181-3 · Cited by 87
ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance
Conrad, C., Benzel, J., Dorzweiler, K., Cook, L., Schlomann, U., Zarbock, A., Slater, E. P., Nimsky, C., & Bartsch, J. W. (2019) · Clinical Science · doi:10.1042/cs20180906 · Cited by 86
Clark, A. M., Wheeler, S., Young, C. L., Stockdale, L., Neiman, J. A. S., Zhao, W., Stolz, D. B., Venkataramanan, R., Lauffenburger, D. A., Griffith, L. G., et al. (2016) · Lab on a Chip · doi:10.1039/c6lc01171c · Cited by 86
Cevatemre, B., Erkısa, M., Aztopal, N., Karakaş, D., Alper, P., Tsimplouli, C., Sereti, E., DIMAS, K. S., Armutak, E. İ., Gürevin, E. G., et al. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.11.027 · Cited by 85
Obesity and Cancer Metastasis: Molecular and Translational Perspectives
Annett, S., Moore, G., & Robson, T. (2020) · Cancers · doi:10.3390/cancers12123798 · Cited by 93
Emerging Topics on Disseminated Cancer Cell Dormancy and the Paradigm of Metastasis
Aguirre‐Ghiso, J. A., & Sosa, M. S. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050446 · Cited by 84
Mechanisms governing metastatic dormancy in breast cancer
Dittmer, J. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.03.006 · Cited by 83
Yang, M. H., Ma, B., Shao, H., Clark, A. M., & Wells, A. H. (2016) · BMC Cancer · doi:10.1186/s12885-016-2411-1 · Cited by 84
Ross, J., Huh, D., Earnest-Noble, L. B., & Tavazoie, S. F. (2015) · Nature Cell Biology · doi:10.1038/ncb3148 · Cited by 81
Molecular Mechanisms of Bone Metastasis.
Weidle, U. H., Birzele, F., Kollmorgen, G., & Rüger, R. (2016) · PubMed · Cited by 79
Long non-coding RNAs and cancer metastasis: Molecular basis and therapeutic implications
Ming, H., Li, B., Zhou, L., Goel, A., & Huang, C. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188519 · Cited by 81
ADAM proteases: Emerging role and targeting of the non-catalytic domains
Saha, N., Tzvetkova‐Robev, D., Himanen, J. P., & Nikolov, D. B. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.10.003 · Cited by 78
Engineered In Vitro Models of Tumor Dormancy and Reactivation
Pradhan, S., Sperduto, J. L., Farino, C. J., & Slater, J. H. (2018) · Journal of Biological Engineering · doi:10.1186/s13036-018-0120-9 · Cited by 77
Bustos, S. O., Antunes, F., Rangel, M. C., & Chammas, R. J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.606436 · Cited by 79
Dormant cancer cells: programmed quiescence, senescence, or both?
Truskowski, K., Amend, S. R., & Pienta, K. J. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10073-z · Cited by 87
Han, H. H., Wang, Y., Curto, J., Gurrapu, S., Laudato, S., Rumandla, A., Chakraborty, G., Wang, X., Chen, H., Jiang, Y., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110595 · Cited by 74
Self-citationAn activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growth
Atapattu, L., Saha, N., Chheang, C., Eissmann, M. F., Xu, K. Y., Vail, M. E., Hii, L. L., Llerena, C., Liu, Z., Horvay, K., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151095 · Cited by 76
Metabolism in cancer metastasis: bioenergetics, biosynthesis, and beyond
Teoh, S. T., & Lunt, S. Y. (2017) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1406 · Cited by 77
Crawford, H. C., di Magliano, M. P., & Banerjee, S. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.042 · Cited by 73
The epigenetic/noncoding origin of tumor dormancy
Crea, F., Saidy, N. R. N., Collins, C. C., & Wang, Y. Z. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.02.005 · Cited by 71
Ramos, G. D. O., Bernardi, L., Lauxen, I. D. S., Filho, M. S., Horwitz, A. R., & Lamers, M. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151338 · Cited by 68
How dormant cancer persists and reawakens
Aguirre‐Ghiso, J. A. (2018) · Science · doi:10.1126/science.aav0191 · Cited by 70
Forward genetic screens in mice uncover mediators and suppressors of metastatic reactivation
Gao, H., Chakraborty, G., Lee-Lim, A. P., Mavrakis, K. J., Wendel, H., & Giancotti, F. G. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403234111 · Cited by 67
Self-citationDisseminated tumor cells and dormancy in prostate cancer metastasis
van der Toom, E. E., Verdone, J. E., & Pienta, K. J. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.02.002 · Cited by 68
LncRNA Malat1 suppresses pyroptosis and T cell-mediated killing of incipient metastatic cells
Kumar, D., Gurrapu, S., Wang, Y., Bae, S., Pandey, P. R., Chen, H., Mondal, J., Han, H. H., Wu, C., Karaiskos, S., et al. (2024) · Nature Cancer · doi:10.1038/s43018-023-00695-9 · Cited by 67
Self-citationWright, K. L., Adams, J. R., Liu, J. C., Loch, A. J., Wong, R. G., Jo, C. E. B., Beck, L. A., Santhanam, D., Weiss, L., Mei, X., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2992 · Cited by 59
Radiation therapy-induced metastasis: radiobiology and clinical implications
Blyth, B. J., Cole, A., MacManus, M. P., & Martin, O. A. (2017) · Clinical & Experimental Metastasis · doi:10.1007/s10585-017-9867-5 · Cited by 65
The Biology and Therapeutic Implications of Tumor Dormancy and Reactivation
Yadav, A. S., Pandey, P. R., Butti, R., Radharani, N. N. V., Roy, S., Bhalara, S. R., Gorain, M., Kundu, G. C., & Kumar, D. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00072 · Cited by 66
Mortezaee, K. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117145 · Cited by 63
Chemotherapy awakens dormant cancer cells in lung by inducing neutrophil extracellular traps
He, D., Wu, Q., Tian, P., Liu, Y., Jia, Z., Li, Z., Wang, Y., Jin, Y., Luo, W., Li, L., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.06.007 · Cited by 69
The role of hepatic macrophages in liver metastasis
Keirsse, J., Damme, H. V., Geeraerts, X., Beschin, A., Raes, G., & Ginderachter, J. A. V. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.03.010 · Cited by 65
Gao, X., Zheng, M. H., Wang, H., Dai, L., Yu, X., Yang, X., Pang, X., Li, L., Zhang, M., Wang, S., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5925-5 · Cited by 62
RetractedThymic Function Associated With Cancer Development, Relapse, and Antitumor Immunity – A Mini-Review
Wang, W., Thomas, R. G., Sizova, O. S., & Su, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00773 · Cited by 64
Tumor Dormancy: Implications for Invasion and Metastasis
Gomatou, G., Syrigos, N. K., Vathiotis, I. A., & Kotteas, E. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094862 · Cited by 63
Neutrophil extracellular traps in cancer
Ma, Y., Wei, J., He, W., & Ren, J. (2024) · MedComm · doi:10.1002/mco2.647 · Cited by 67
Mishra, S., Bernal, C., Silvano, M., Anand, S., & Altaba, A. R. I. (2019) · Oncogene · doi:10.1038/s41388-019-0845-z · Cited by 55
Circulating proteins as predictive and prognostic biomarkers in breast cancer
Veyssière, H., Bidet, Y., Penault-Llorca, F. M., Radosevic‐Robin, N., & Durando, X. (2022) · Clinical Proteomics · doi:10.1186/s12014-022-09362-0 · Cited by 59
Therapeutic potential and limitations of curcumin as antimetastatic agent
Dytrych, P., Kejík, Z., Hajduch, J., Kaplánek, R., Veselá, K., Kučnirová, K., Skaličková, M., Venhauerova, A., Hoskovec, D., Pavel Martasek, E., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114758 · Cited by 62
The emerging molecular machinery and therapeutic targets of metastasis
Sun, Y., & Ma, L. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.001 · Cited by 61
Evolving Strategies for Therapeutically Targeting Cancer Stem Cells
Talukdar, S., Emdad, L., Das, S. K., Sarkar, D., & Fisher, P. B. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.04.003 · Cited by 59
RCAN1-4 is a thyroid cancer growth and metastasis suppressor
Wang, C., Saji, M., Justiniano, S. E., Yusof, A. M., Zhang, X., Yu, L., Fernández, S., Wakely, P. E., Perle, K. L., Nakanishi, H., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.90651 · Cited by 59
The Emerging Role of Osteocytes in Cancer in Bone
Atkinson, E. G., & Delgado‐Calle, J. (2019) · JBMR Plus · doi:10.1002/jbm4.10186 · Cited by 58
Drug Development for Metastasis Prevention
Fontebasso, Y., & Dubinett, S. M. (2015) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v20.i5-6.150 · Cited by 57
Sauer, S. J., Reed, D. R., Ihnat, M. A., Hurst, R. E., Warshawsky, D., & Barkan, D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.659963 · Cited by 59
Wu, L.-F., Han, L., Zhou, C., Wei, W.-F., Chen, X., Yi, H., Wu, X., Bai, X., Guo, S., Yu, Y., et al. (2017) · FEBS Journal · doi:10.1111/febs.14162 · Cited by 56
Potential Markers from Serum-Purified Exosomes for Detecting Oral Squamous Cell Carcinoma Metastasis
Li, C., Zhou, Y., Liu, J., Su, X., Qin, H., Huang, S.-H., Huang, X., & Zhou, N. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-1122 · Cited by 56
Cancer stem cells and tumor heterogeneity: Deciphering the role in tumor progression and metastasis
Kapoor-Narula, U., & Lenka, N. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155968 · Cited by 59
The role of tumor microenvironment on cancer stem cell fate in solid tumors
Razi, S., Haghparast, A., Khameneh, S. C., Sadrabadi, A. E., Aziziyan, F., Bakhtiyari, M., Nabi‐Afjadi, M., Tarhriz, V., Jalili, A., & Zalpoor, H. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01129-w · Cited by 56
Bonuccelli, G., Peiris‐Pagès, M., Ózsvári, B., Martinez‐Outschoorn, U., Sotgia, F., & Lisanti, M. P. (2016) · Oncotarget · doi:10.18632/oncotarget.14196 · Cited by 55
Jiang, J., Zheng, M., Zhang, M., Yang, X., Li, L., Wang, S.-S., Wu, J.-S., Yu, X.-H., Wu, J.-B., Pang, X., et al. (2019) · Neoplasia · doi:10.1016/j.neo.2018.12.001 · Cited by 54
Modeling metastasis in mice: a closer look
Giacobbe, A., & Abate-Shen, C. T. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.06.010 · Cited by 51
Phenotypic plasticity during metastatic colonization
Jehanno, C., Vulin, M., Richina, V., Richina, F., & Bentires‐Alj, M. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.03.007 · Cited by 60
Martirosian, V., Deshpande, K., Zhou, H., Shen, K., Smith, K. S., Northcott, P. A., Lin, M. P., Stepanosyan, V., Das, D., Remšík, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109302 · Cited by 55
Emerging and Established Models of Bone Metastasis
Jinnah, A. H., Zacks, B. C., Gwam, C. U., & Kerr, B. A. (2018) · Cancers · doi:10.3390/cancers10060176 · Cited by 50
Expansion of cancer stem cell pool initiates lung cancer recurrence before angiogenesis
Li, L., Li, J.-C., Yang, H., Zhang, X., Liu, L., Li, Y., Zeng, T., Zhu, Y.-H., Li, X.-D., Li, Y., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806219115 · Cited by 53
Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity
Saxena, S., & Singh, R. K. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09970-6 · Cited by 54
In vitro Models of Breast Cancer Metastatic Dormancy
Montagner, M., & Sahai, E. A. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00037 · Cited by 50
Cancer stem cells: a challenging paradigm for designing targeted drug therapies
Khan, I. N., Alkarim, S., Bora, R. S., Chaudhary, A., & Saini, K. S. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.06.013 · Cited by 51
Next generation organoid engineering to replace animals in cancer drug testing
Hockney, S., Parker, J., Turner, J. E., Todd, X., Todryk, S. M., Gieling, R. G., Hilgen, G., Simoes, D. C. M., & Pal, D. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115586 · Cited by 54
Lo, P., Yao, Y., Lee, J. S., Zhang, Y., Huang, W., Kane, M. A., & Zhou, Q. Y. (2018) · eLife · doi:10.7554/elife.31334 · Cited by 50
Dormancy in Breast CancerPreprint
Dalla, E., Sreekumar, A., Aguirre‐Ghiso, J. A., & Chodosh, L. A. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041331 · Cited by 52
Guo, W. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0020 · Cited by 52
Liu, X., Tang, L., Du, X.-J., Li, W., Chen, L., Zhou, G., Guo, R., Liu, Q., Sun, Y. H., & Ma, J. (2017) · Journal of Cancer · doi:10.7150/jca.17104 · Cited by 49
COX-2 mediates tumor-stromal prolactin signaling to initiate tumorigenesis
Zheng, Y., Comaills, V., Burr, R., Boulay, G., Miyamoto, D. T., Wittner, B. S., Emmons, E., Sil, S., Koulopoulos, M. W., Broderick, K. T., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1819303116 · Cited by 49
The bone marrow niche in support of breast cancer dormancy
Walker, N. D., Patel, J. S., Munoz, J. L., Hu, M. D., Guiro, K., Sinha, G., & Rameshwar, P. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.033 · Cited by 47
Prevention of cancer dormancy by Fbxw7 ablation eradicates disseminated tumor cells
Shimizu, H., Takeishi, S., Nakatsumi, H., & Nakayama, K. I. (2019) · JCI Insight · doi:10.1172/jci.insight.125138 · Cited by 53
Anlaş, A. A., & Nelson, C. M. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-4021 · Cited by 48
Exploring the Wnt Pathway as a Therapeutic Target for Prostate Cancer
Koushyar, S., Méniel, V. S., Phesse, T. J., & Pearson, H. B. (2022) · Biomolecules · doi:10.3390/biom12020309 · Cited by 48
Breast Cancer Metastatic Dormancy and Relapse: An Enigma of Microenvironment(s)
Elkholi, I. E., Lalonde, A., Park, M., & Côté, J. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-1902 · Cited by 48
Targeting Cancer Cell Metastasis by Converting Cancer Cells into Fat
Ishay-Ronen, D., & Christofori, G. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1242 · Cited by 47
Rossari, F., Zucchinetti, C., Buda, G., & Orciuolo, E. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00467-7 · Cited by 46
Grainyhead‐like 2 ( GRHL 2) regulates epithelial plasticity in pancreatic cancer progression
Nishino, H., Takano, S., Yoshitomi, H., Suzuki, K., Kagawa, S., Shimazaki, R., Shimizu, H., Furukawa, K., Miyazaki, M., & Ohtsuka, M. (2017) · Cancer Medicine · doi:10.1002/cam4.1212 · Cited by 44
Lee, J., Kim, H.-I., Kim, M. G., Ha, T. K., Jung, M.-S., & Kwon, S. J. (2015) · Surgery · doi:10.1016/j.surg.2015.11.002 · Cited by 46
Hu, Q., Wang, K., Sun, X. D., Li, Y., Fu, Q., Liang, T., & Tang, G. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.07.016 · Cited by 45
CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells
Maeda, K., Ding, Q., Yoshimitsu, M., Kuwahata, T., Miyazaki, Y., Tsukasa, K., Hayashi, T., Shinchi, H., Natsugoe, S., & Takao, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071025 · Cited by 45
Mesenchymal Stromal Cells: Emerging Roles in Bone Metastasis
Graham, N., & Qian, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041121 · Cited by 45
Schell, M. J., Yang, M., Missiaglia, E., Delorenzi, M., Soneson, C., Yue, B., Nebozhyn, M. V., Loboda, A., Bloom, G., & Yeatman, T. J. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0143 · Cited by 42
Wang, J., Ocádiz-Ruiz, R., Hall, M. S., Bushnell, G. G., Orbach, S. M., Decker, J. T., Raghani, R. M., Zhang, Y., Morris, A. H., Jeruss, J. S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40478-5 · Cited by 46
Muramatsu, T., Kozaki, K., Imoto, S., Yamaguchi, R., Tsuda, H., Kawano, T., Fujiwara, N., Morishita, M., Miyano, S., & Inazawa, J. (2016) · Oncogene · doi:10.1038/onc.2016.71 · Cited by 43
Natural and chemotherapy-induced clonal evolution of tumors
Ibragimova, M. K., Tsyganov, M. M., & Литвяков, Н. В. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917040022 · Cited by 44
Signaling by discoidin domain receptor 1 in cancer metastasis
Gadiya, M. M., & Chakraborty, G. (2018) · Cell Adhesion & Migration · doi:10.1080/19336918.2018.1520556 · Cited by 46
Out of the cycle: Impact of cell cycle aberrations on cancer metabolism and metastasis
Cheung, A. H. K., Hui, C. H., Wong, K. Y., Liu, X., Chen, B., Kang, W., & To, K. F. (2022) · International Journal of Cancer · doi:10.1002/ijc.34288 · Cited by 47
Downregulation of CXCR4 in Metastasized Breast Cancer Cells and Implication in Their Dormancy
Nobutani, K., Shimono, Y., Mizutani, K., Ueda, Y., Suzuki, T., Kitayama, M., Minami, A., Momose, K., Miyawaki, K., Akashi, K., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130032 · Cited by 43
Tumor Cell Dormancy and Reactivation in Bone: Skeletal Biology and Therapeutic Opportunities
Byrne, N. M., Summers, M. A., & McDonald, M. M. (2018) · JBMR Plus · doi:10.1002/jbm4.10125 · Cited by 47
The senescent microenvironment promotes the emergence of heterogeneous cancer stem-like cells
Castro‐Vega, L. J., Jouravleva, K., Ortíz-Montero, P., Liu-Bordes, W.-Y., Galeano, J. L., Romero, M. L., Popova, T. G., Bacchetti, S., Vernot, J., & Londoño‐Vallejo, A. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv101 · Cited by 43
EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours
Toosi, B. M., Zawily, A. E., Truitt, L., Shannon, M., Allonby, O., Babu, M., DeCoteau, J. F., Mousseau, D. D., Ali, M., Freywald, T., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0228-x · Cited by 43
Clark, A. M., Heusey, H. L., Griffith, L. G., Lauffenburger, D. A., & Wells, A. H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.676135 · Cited by 41
A genetic screen in Drosophila for regulators of human prostate cancer progression
Ito, S., Ueda, T., Ueno, A., Nakagawa, H., Taniguchi, H., Kayukawa, N., & Miki, T. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.015 · Cited by 42
Bleckmann, A., Conradi, L., Menck, K., Schmick, N. A., Schubert, A., Rietkötter, E., Arackal, J., Middel, P., Schambony, A., Liersch, T., et al. (2016) · Clinical and Experimental Metastasis · doi:10.1007/s10585-016-9780-3 · Cited by 38
Modeling angiogenesis with micro- and nanotechnology
Chen, L.-J., & Kaji, H. (2017) · Lab on a Chip · doi:10.1039/c7lc00774d · Cited by 44
Ghouse, S. M., Vadrevu, S. K., Manne, S., Reese, B., Patel, J., Patel, B. B., Silwal, A., Lodhi, N., Paterson, Y. Y. W., Srivastava, S., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901208 · Cited by 41
A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor
Mei, W., Tabrizi, S. F., Godina, C., Lovisa, A. F., Isaksson, K., Jernström, H., & Tavazoie, S. F. (2024) · Cell · doi:10.1016/j.cell.2024.11.009 · Cited by 43
Correnti, M., & Raggi, C. (2016) · Oncotarget · doi:10.18632/oncotarget.12569 · Cited by 42
Cellular Phenotype Plasticity in Cancer Dormancy and Metastasis
Yang, X., Liang, X., Zheng, M. H., & Tang, Y. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00505 · Cited by 42
Yu, R., Longo, J., van Leeuwen, J. E., Zhang, C., Branchard, E., Elbaz, M., Cescon, D. W., Drake, R. R., Dennis, J. W., & Penn, L. Z. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2642 · Cited by 40
Leptomeningeal dissemination in pediatric brain tumors
Cocito, C., Martin, B., Giantini-Larsen, A., Valcarce‐Aspegren, M., Souweidane, M. M., Szalontay, L., Dahmane, N., & Greenfield, J. P. (2023) · Neoplasia · doi:10.1016/j.neo.2023.100898 · Cited by 41
Wnt signalling in gynaecological cancers: A future target for personalised medicine?
Ford, C. E., Henry, C. E., Llamosas, E., Djordjevic, A., & Hacker, N. F. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.09.085 · Cited by 39
Metadata
- Authors
- Giancotti, F. G.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Giancotti, Filippo G.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 155
- Issue
- 4
- Pages
- 750-764
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC4354734
- OpenAlex
- W2088035579
- Cited by
- 586
- References
- 143
- Citations by year
- 2026: 20 · 2025: 35 · 2024: 45 · 2023: 68 · 2022: 47 · 2021: 50 · 2020: 53 · 2019: 47 · 2018: 53 · 2017: 39 · 2016: 57 · 2015: 44 · 2014: 28
- FWCI
- 4.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA175712)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- metastatic dormancy, cancer stem cells, metastasis-initiating cells, Wnt signaling, Notch signaling, BMP signaling, metastatic relapse, therapeutic interventions
- MeSH terms
- Animals, Extracellular Matrix, Humans, Neoplasm Metastasis, Neoplasms, Neoplastic Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review